Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Change of Lifestyle by Persons in Risk of Type 2 Diabetes

The recruitment status of this study is unknown because the information has not been verified recently.
Verified December 2003 by Sorlandet Hospital HF.
Recruitment status was  Active, not recruiting
Sponsor:
Information provided by:
Sorlandet Hospital HF
ClinicalTrials.gov Identifier:
NCT00202748
First received: September 12, 2005
Last updated: December 22, 2005
Last verified: December 2003
  Purpose

We know that changing lifestyle can prevent type 2 diabetes. The challenge is how to help people changing their lifestyle. We have people in 2 groups: half of them is meeting in grops of 10 persons (interventiongroup), the other ones are just visiting their doctor (controlgroup).


Condition Intervention Phase
Type 2 Diabetes
Behavioral: Increase in activity to control weight
Behavioral: Increase in activity to control weight.
Phase 3

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Prevention
Official Title: Phase 3 Study of Changing of Lifestyle by Persons in Risk of Type 2 Diabetes

Resource links provided by NLM:


Further study details as provided by Sorlandet Hospital HF:

Primary Outcome Measures:
  • Weigtreduction
  • Increase in maximum oxygen uptake
  • Change in foodintake
  • Change in self-reported activity

Secondary Outcome Measures:
  • Quality of life

Estimated Enrollment: 220
Study Start Date: March 2004
Estimated Study Completion Date: March 2007
Detailed Description:

The intervention group are meeting different healt proffesionals (nurse, doctor, eksperts on nutrition,experts on activity and experts on how to change. They have 7 meetings in groups of 10 persons over 3 months. The controlgroup are just meeting their own doctor or the doctor in the hospital 2 times a year.

We tell all that small changes are making big differenses (in weight and the chanse of getting ill). Everyone is told that lack of aktivity is the main reason to obesity. Lack of activity also influense in whar you eat. herefore is activity in the "center".

  Eligibility

Ages Eligible for Study:   20 Years to 64 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria: Diabetes risk score above 9 points.

Exclusion Criteria: Persons with diabetes, serious heart disease, cancer or psychiatric disorder. They have to speak and understand Norwegian language.

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00202748

Locations
Norway
Sorlandet Hospital
Kristiansand, Serviceboks 416, Norway, 4604
Sponsors and Collaborators
Sorlandet Hospital HF
Investigators
Study Chair: Frode Gallefoss, Dr.
  More Information

No publications provided by Sorlandet Hospital HF

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
ClinicalTrials.gov Identifier: NCT00202748     History of Changes
Other Study ID Numbers: SSHF70201
Study First Received: September 12, 2005
Last Updated: December 22, 2005
Health Authority: Norway: Norwegian Social Science Data Services

Keywords provided by Sorlandet Hospital HF:
metabolic syndrome
lifestyle
obesity

Additional relevant MeSH terms:
Diabetes Mellitus
Diabetes Mellitus, Type 2
Endocrine System Diseases
Glucose Metabolism Disorders
Metabolic Diseases

ClinicalTrials.gov processed this record on November 20, 2014